Cited in:


This article has been cited by:

  1. 1
    Adrian Marchidann, Clotilde Balucani, Steven R. Levine, Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria, Neurologic Clinics, 2015, 33, 2, 381


  2. 2
    E. T. Thortveit, M. G. Bøe, U. Ljøstad, Å. Mygland, A. Tveiten, Organizational changes aiming to reduce iv tPA door-to-needle time, Acta Neurologica Scandinavica, 2014, 130, 4
  3. 3
    Xin Tong, Mary G. George, Quanhe Yang, Cathleen Gillespie, Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008–2012, International Journal of Stroke, 2014, 9, 6